Gossamer Bio, Inc. 8K

Gossamer Bio, Inc. established the terms of a new Series A-1 Convertible Preferred Stock, including senior ranking, a 4x liquidation preference, and conditional conversion into common stock upon stockholder approval.

Gossamer Bio, Inc. adopted a Certificate of Designation creating a new series of preferred stock, the Series A-1 Convertible Preferred Stock, authorizing 25,000 shares at an original price of $1,000 per share, initially ranking senior to common stock with a 4x liquidation preference prior to stockholder approval, and setting detailed terms for dividends, limited voting and protective provisions, conversion mechanics at an initial $0.14 per-share conversion price (subject to Nasdaq stockholder approval and ownership caps), anti-dilution adjustments, and procedures for obtaining the requisite stockholder approval to permit full conversion into common stock.

Filing Facts

CIK

1728117

Ticker

-

Form

8K

Source Type

sec

Accession

0001728117-26-000077

Alert Tier

6